Drawing for IBIS BIOSCIENCES

USPTO serial 78844073

IBIS BIOSCIENCES

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PILARO, MARK F
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IBIS BIOSCIENCES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mary L. Winburn

Mary L. Winburn Abbott Laboratories100 Abbott Park RoadD377/AP6AAbbott Park, IL 60064-6008

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in science, industry and agriculture, namely, compounds and reagents for scientific or research use for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; compounds and reagents for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific or research use; kits comprising compounds and reagents for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific or research use; kits comprising compounds and reagents for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific or research use; single-use laboratory articles and arrays consisting of chemical kits comprising compounds and reagents for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific or research use; single-use laboratory articles and arrays consisting of chemical kits comprising compounds and reagents for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific or research use; diagnostic preparations for scientific or research use for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; diagnostic preparations for scientific or research use for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogensACTIVE—
005Chemicals used for medical purposes, namely, compounds and reagents for medical use for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; compounds and reagents for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; kits comprising compounds and reagents for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; kits comprising compounds and reagents for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; single-use laboratory articles and arrays consisting of chemical kits comprising compounds and reagents for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; single-use laboratory articles and arrays consisting of chemical kits comprising compounds and reagents for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; diagnostic preparations for medical use for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; diagnostic preparations for medical use for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogensACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 28, 2010MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 28, 2010ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 3, 2009EX5GSOU EXTENSION 5 GRANTED—
Nov 2, 2009EXT5SOU EXTENSION 5 FILED—
Nov 2, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 28, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 28, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 11, 2009EX4GSOU EXTENSION 4 GRANTED—
Mar 9, 2009EXT4SOU EXTENSION 4 FILED—
Mar 9, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 17, 2008ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 1, 2008EX3GSOU EXTENSION 3 GRANTED—
Dec 1, 2008AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 25, 2008EXT3SOU EXTENSION 3 FILED—
Nov 25, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 2, 2008EX2GSOU EXTENSION 2 GRANTED—
May 27, 2008EXT2SOU EXTENSION 2 FILED—
May 27, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 18, 2007EX1GSOU EXTENSION 1 GRANTED—
Nov 28, 2007EXT1SOU EXTENSION 1 FILED—
Nov 28, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 29, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 6, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 14, 2007NPUBNOTICE OF PUBLICATION—
Jan 12, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 8, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 8, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Jan 8, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 8, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 4, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 4, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 4, 2007ALIEASSIGNED TO LIE—
Nov 29, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 6, 2006GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 6, 2006CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 7, 2006DOCKASSIGNED TO EXAMINER—
Apr 11, 2006MPMKNOTICE OF PSEUDO MARK MAILED—
Mar 29, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance